Literature DB >> 7513193

Mutations in the Fas antigen gene in lpr mice.

S Nagata1.   

Abstract

The Fas antigen is a cell surface protein belonging to the tumor necrosis factor/nerve growth factor receptor family and it mediates apoptosis. The Fas antigen gene is the structural gene for the mouse mutation, lpr (lymphoproliferation). In one allele of lpr, an early transposable element (a mouse endogenous retrovirus) is inserted into an intron of the Fas antigen gene, which causes premature termination and aberrant splicing of the Fas antigen transcript. In the other allele (lprcg), a point mutation in the signal transducing domain of the cytoplasmic region abolishes the function of the Fas antigen.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513193     DOI: 10.1006/smim.1994.1002

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  15 in total

1.  Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients.

Authors:  T Otsuki; A Tomokuni; H Sakaguchi; T Aikoh; T Matsuki; Y Isozaki; F Hyodoh; H Ueki; M Kusaka; S Kita; A Ueki
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

Review 2.  Neuroimmunopathology in a murine model of neuropsychiatric lupus.

Authors:  David A Ballok
Journal:  Brain Res Rev       Date:  2006-12-20

3.  Endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls B-cell immunity through degradation of the death receptor CD95/Fas.

Authors:  Sinyi Kong; Yi Yang; Yuanming Xu; Yajun Wang; Yusi Zhang; Johanna Melo-Cardenas; Xiangping Xu; Beixue Gao; Edward B Thorp; Donna D Zhang; Bin Zhang; Jianxun Song; Kezhong Zhang; Jianning Zhang; Jinping Zhang; Huabin Li; Deyu Fang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-29       Impact factor: 11.205

4.  Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.

Authors:  W A Faubion; M E Guicciardi; H Miyoshi; S F Bronk; P J Roberts; P A Svingen; S H Kaufmann; G J Gores
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

5.  A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis.

Authors:  K Chu; X Niu; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

6.  Efficient analysis of mouse genome sequences reveal many nonsense variants.

Authors:  Sophie Steeland; Steven Timmermans; Sara Van Ryckeghem; Paco Hulpiau; Yvan Saeys; Marc Van Montagu; Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-04       Impact factor: 11.205

7.  Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease.

Authors:  M Y Braun; B Lowin; L French; H Acha-Orbea; J Tschopp
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

8.  Correlations between gene expression and mercury levels in blood of boys with and without autism.

Authors:  Boryana Stamova; Peter G Green; Yingfang Tian; Irva Hertz-Picciotto; Isaac N Pessah; Robin Hansen; Xiaowei Yang; Jennifer Teng; Jeffrey P Gregg; Paul Ashwood; Judy Van de Water; Frank R Sharp
Journal:  Neurotox Res       Date:  2009-11-24       Impact factor: 3.911

9.  Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.

Authors:  Lilia L Bi; George Pan; T Prescott Atkinson; Lixin Zheng; Janet K Dale; Christopher Makris; Vishnu Reddy; Jay M McDonald; Richard M Siegel; Jennifer M Puck; Michael J Lenardo; Stephen E Straus
Journal:  BMC Med Genet       Date:  2007-07-02       Impact factor: 2.103

10.  In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.

Authors:  Iotefa Teiti; Bertrand Florie; Christine Pich; Rémi Gence; Isabelle Lajoie-Mazenc; Philippe Rochaix; Gilles Favre; Anne-Françoise Tilkin-Mariamé
Journal:  Front Oncol       Date:  2015-07-14       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.